UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011869
Receipt number R000010068
Scientific Title Relationship Between Arteriosclerosis Obliterans and Serum Level of Eicosapentaenoic Acid as Prospective Interventional Study
Date of disclosure of the study information 2013/09/26
Last modified on 2015/01/16 08:44:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship Between Arteriosclerosis Obliterans and Serum Level of Eicosapentaenoic Acid as Prospective Interventional Study

Acronym

EPA Prospective (EPAP)

Scientific Title

Relationship Between Arteriosclerosis Obliterans and Serum Level of Eicosapentaenoic Acid as Prospective Interventional Study

Scientific Title:Acronym

EPA Prospective (EPAP)

Region

Japan


Condition

Condition

Arteriosclerosis Obliterans

Classification by specialty

Vascular surgery Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy of EPA to ASO

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

6 minutes walking test

Key secondary outcomes

Fontain's class, ABPI, SPP, ammonia PET, incidence of AMI, stroke and cardiovascular death


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

cilostazol
200 mg/day
6 months

Interventions/Control_2

cilostazol
200 mg /day
eicosapentaenoic acid
1800 mg/day
6 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

21 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

ASO patients with intermittent claudication

Key exclusion criteria

none

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shoji Fukuda

Organization

National Center for Global Health and Medicine

Division name

Cardiovascular Surgery

Zip code


Address

1-21-1,Toyama,Shinjuku,Tokyo

TEL

03-3202-7181

Email

sfukuda@hosp.ncgm.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Secretariat

Organization

National Center for Global Health and Medicine

Division name

Cardiovascular Surgery

Zip code


Address

1-21-1,Toyama,Shinjuku,Tokyo

TEL

03-3202-7181

Homepage URL


Email

shinzou.gimu@hosp.ncgm.go.jp


Sponsor or person

Institute

National Center for Global Health and Medicine
Department of Cardiovascular Surgery

Institute

Department

Personal name



Funding Source

Organization

National Center for Global Health and Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立国際医療研究センター(東京都)
National Center for Global Health and Medicine (Tokyo)


Other administrative information

Date of disclosure of the study information

2013 Year 09 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 06 Month 04 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 09 Month 26 Day

Last modified on

2015 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010068


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name